Hjem › Pulmonal arteriell hypertensjon › California
Kliniske studier for Pulmonal arteriell hypertensjon i California
12 studier for Pulmonal arteriell hypertensjon søker deltakere på steder i California.
Byer i California
- Mountain View7 studier
- Los Angeles4 studier
- Sacramento3 studier
- Santa Barbara3 studier
- San Francisco3 studier
Offisiell studietekst (engelsk)
A Clinical Study of Sotatercept (MK-7962) in People With Pulmonary Arterial Hypertension (MK-7962-038)
- UC Davis - Medial Center ( Site 1064), Sacramento
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 1. okt. 2026 · NCT07218029A Study to Evaluate the Efficacy and Safety of Once Daily Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Arterial Hypertension (PAH)
- USA012, Los Angeles
- USA008, Santa Barbara
- USA005, Torrance
RekruttererFase 3
Alder 18 til 75 · Alle kjønn · Oppdatert 16. sep. 2026 · NCT07481981An Adaptive Program of IKT-001 in Pulmonary Arterial Hypertension (PAH)
- Cedars Sinai, Beverly Hills
- Jeffrey S. Sager, MD Medical Corporation, Santa Barbara
- Lundquist at Harbor UCLA, Torrance
RekruttererFase 3
Alder 18 til 75 · Alle kjønn · Oppdatert 2. sep. 2026 · NCT07365332Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)
- Lucile Packard Children's Hospital, Palo Alto
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
Alder 0 til 20 · Alle kjønn · Oppdatert 21. aug. 2026 · NCT04278404A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY)
- University of California Davis Health, Rancho Cordova
RekruttererFase 2
Alder 18 til 80 · Alle kjønn · Oppdatert 10. aug. 2026 · NCT07175038Open-label Extension Study of Seralutinib in Adult Subjects With PAH (PROSERA-EXT)
- Valley Advanced Lung Diseases Institute, Fresno
- Department of Veterans Affairs Greater Los Angeles Healthcare System, Los Angeles
- UC Davis Health Medical Center, Sacramento
- og 1 flere
RekruttererFase 3
Alder 18 til 75 · Alle kjønn · Oppdatert 29. jul. 2026 · NCT06274801A Study to Learn About the Treatment LTP001 in Healthy Participants (Part A) and in Participants With PAH (Part B)
- UC Irvine Medical Center, Orange
- Stanford Medical Center, Stanford
RekruttererFase 1/2Frivillige helsepersonell ønskes velkommen
Alder 18 til 100 · Alle kjønn · Oppdatert 21. jul. 2026 · NCT06649110A Study Evaluating the Safety and Tolerability of Artesunate in Patients With Pulmonary Arterial Hypertension
- Stanford University, Stanford
RekruttererFase 1
Alder 18 til 60 · Alle kjønn · Oppdatert 23. apr. 2026 · NCT06872112Study to Evaluate Sotatercept (MK-7962) in Children With Pulmonary Arterial Hypertension (PAH) (MK-7962-008)
- The Regents of the University of California - Los Angeles (UCLA Pediatrics) ( Site 1606), Los Angeles
- Stanford University School of Medicine ( Site 1603), Palo Alto
- UCSF Benioff Children's Hospital San Francisco ( Site 1611), San Francisco
RekruttererFase 2
Alder 1 til 17 · Alle kjønn · Oppdatert 20. apr. 2026 · NCT05587712Pulmonary Hypertension Association Registry
- UC Davis Health, Sacramento
- UCSF Medical Center, San Francisco
- UCSF Benioff Children's Hospital, San Francisco
- og 2 flere
RekruttererObservasjonsstudie
Alder 0 og eldre · Alle kjønn · Oppdatert 14. nov. 2025 · NCT04071327Treatment of Pulmonary Arterial Hypertension Using the Aria CV Pulmonary Hypertension System
- University of California-Los Angeles, Los Angeles
Rekrutterer
Alder 18 og eldre · Alle kjønn · Oppdatert 29. sep. 2025 · NCT04555161Pediatric Pulmonary Hypertension Network (PPHNet) Informatics Registry
- Stanford University Medical Center, Palo Alto
- University California San Francisco, San Francisco
RekruttererObservasjonsstudie
1 Day – 21 Years · Alle kjønn · Oppdatert 13. mar. 2025 · NCT02249923Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.